Literature DB >> 10385781

Improved endocardial visualization with second harmonic imaging compared with fundamental two-dimensional echocardiographic imaging.

R Senior1, P Soman, R S Khattar, A Lahiri.   

Abstract

BACKGROUND: Endocardial visualization is suboptimal by fundamental imaging in at least 30% of patients. Second harmonic imaging was developed for visualization of myocardial contrast agents. We have hypothesized that endocardial visualization may improve with harmonic imaging compared with fundamental imaging. METHODS AND
RESULTS: Accordingly, 40 consecutive patients with poor endocardial visualization by conventional echocardiography in at least 1 left ventricular segment (22-segment model) in the 4 standard views randomly underwent fundamental and harmonic imaging without contrast. The images were separately and randomly analyzed by 2 observers. Endocardial visualization was scored as 0, not visualized; 1, poorly visible; and 2, well visualized. Endocardial visualization indexes were also calculated. More segments were assigned a score of 0 (P <. 001) and 1 (P <.001) by fundamental compared with harmonic imaging, whereas harmonic imaging demonstrated more segments with a score of 2 (P <.001) compared with fundamental imaging. Endocardial visualization indexes were significantly better by harmonic imaging in the parasternal long axis (P <.005), short axis (P <.001), and apical 4- (P <.0001) and 2-chamber views (P <.0001). Similar results were obtained by a second observer. Agreement between the 2 observers regarding improvement, deterioration, or no change in score between harmonic and fundamental imaging was 88% (kappa = 0. 76). Interobserver and intraobserver agreements for systolic wall thickening scores also significantly improved with harmonic compared with fundamental imaging (P <.001).
CONCLUSION: Second harmonic imaging is superior to fundamental imaging for endocardial visualization in patients with suboptimal fundamental imaging.

Entities:  

Mesh:

Year:  1999        PMID: 10385781     DOI: 10.1016/s0002-8703(99)70263-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Contrast echocardiography for left ventricular opacification.

Authors:  J Timperley; A R J Mitchell; H Becher
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

2.  Comparison of treadmill exercise stress cardiac MRI to stress echocardiography in healthy volunteers for adequacy of left ventricular endocardial wall visualization: A pilot study.

Authors:  Paaladinesh Thavendiranathan; Jennifer A Dickerson; Debbie Scandling; Vijay Balasubramanian; Michael L Pennell; Alice Hinton; Subha V Raman; Orlando P Simonetti
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

3.  Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.

Authors:  F B Sozzi; D Poldermans; J J Bax; A Elhendy; E C Vourvouri; R Valkema; J De Sutter; A F Schinkel; A Borghetti; J R Roelandt
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.

Authors:  N P Nikitin; P H Loh; R de Silva; J Ghosh; O Y Khaleva; K Goode; A S Rigby; F Alamgir; A L Clark; J G F Cleland
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

5.  A prospective comparison of echocardiographic wall motion score index and radionuclide ejection fraction in predicting outcome following acute myocardial infarction.

Authors:  G I Galasko; S Basu; A Lahiri; R Senior
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

6.  Ultrasound evaluation of normal and abnormal fetuses: comparison of conventional, tissue harmonic, and pulse-inversion harmonic imaging techniques.

Authors:  Jeong-Ah Ryu; Bohyun Kim; Sooah Kim; Soon Ha Yang; Moon Hae Choi; Hyeong Sik Ahn
Journal:  Korean J Radiol       Date:  2003 Jul-Sep       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.